MARISSA MORITZ-GUZIK: Open Payments
NPI 1457669772 · LOUISVILLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66,920 in 230 payments from 16 companies in 2025. Trend: 2023 $2,627 · 2024 $21,141 · 2025 $66,920
Speaker / faculty: $48,182Travel & lodging: $11,746Food & beverage: $4,442Consulting: $2,550
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 47 | $38,095 |
| Lilly USA, LLC | 58 | $25,967 |
| ABBVIE INC. | 37 | $679 |
| Madrigal Pharmaceuticals | 9 | $536 |
| GENZYME CORPORATION | 11 | $364 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $309 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $239 |
| Phathom Pharmaceuticals, Inc. | 12 | $235 |
| Gilead Sciences, Inc. | 7 | $154 |
| Aimmune Therapeutics, Inc. | 4 | $76 |
Products named: TREMFYA, OMVOH, STELARA, REZDIFFRA, DUPIXENT, XIFAXAN, VOQUEZNA, SKYRIZI.
Industry payments across CO — which companies pay providers there.
